Has Vladimir Milo, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,788 in general payments to Vladimir Milo, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vladimir Milo, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vladimir Milo, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vladimir Milo, MD

Internal Medicine · Fenton, MONPI 1609848852

Payments from drug & device makers

$2,788in general payments, 2019–2025

Across 143 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$823
OPKO Pharmaceuticals, LLC$283
Vifor Pharma, Inc.$256
Bayer$237
Fresenius USA Marketing, Inc.$192
Amgen$115
plus $882 from 19 others

What the payments were for

Food & beverage$2,75399%
Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	46	$823
OPKO Pharmaceuticals, LLC	13	$283
Vifor Pharma, Inc.	15	$256
Bayer	11	$237
Fresenius USA Marketing, Inc.	10	$192
Amgen(2 entities)	6	$115
Calliditas Therapeutics US Inc.	3	$80
E.r. Squibb & Sons, L.L.C.	5	$76
Daiichi Sankyo Inc.	4	$75
Aurinia Pharma U.S., Inc.	3	$72
Mallinckrodt Hospital Products Inc.	3	$72
AstraZeneca	4	$71
Travere Therapeutics, Inc.	3	$69
Portola Pharmaceuticals, LLC	2	$68
Novartis	2	$49
Takeda Pharmaceuticals U.S.A., Inc.	2	$37
Pharmacosmos Therapeutics Inc.	2	$37
Boehringer Ingelheim	2	$36
Mallinckrodt Enterprises LLC	1	$25
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$24
Ardelyx, Inc.	1	$23
Scpharmaceuticals Inc.	1	$20
Akebia Therapeutics Inc	1	$17
Shire North American Group Inc	1	$17
Shield Therapeutics Inc	1	$14

How this compares

$2,788 in reported general payments places this provider in the 80th percentile of 2,097 internal medicine providers in Missouri.

See all internal medicine providers in Missouri →

Medicare billing

Part B allowed, 2024

$41,480

Medicare patients

111

Services billed

409

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	20	$6,575
Oxycodone Hcl	94	$1,161
Duloxetine Hcl	28	$905
Atorvastatin Calcium	45	$898
Mirtazapine	14	$536
Tamsulosin Hcl	28	$471
Torsemide	20	$465
Levothyroxine Sodium	35	$453
Metoprolol Succinate	22	$451
Gabapentin	16	$450
Lisinopril	34	$430
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	42	$412
Potassium Chloride	20	$403
Metformin Hcl	21	$402
Escitalopram Oxalate	25	$373

Paid to pharmacies, not to this prescriber.

Other internal medicine in Fenton

Timothy SmithSaint Peters$21.4M
Craig DietzKansas City$4M
Michael ReschakSaint Louis$3.1M
Dima DandachiColumbia$1.2M
Santosh SharmaKansas City$782K
Jianbo WangChesterfield$643K
David PrelutskySaint Louis$575K
Danish JabbarSaint Louis$510K
Dubert GuerreroIndependence$369K
Hany SalamaSaint Louis$279K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →